The Recall Desk
SevereFDA (Devices)·Z-1285-2024·Announced 2024-04-03

Nimbus Ambulatory Infusion Pump recalled due to multiple failure modes

InfuTronix is recalling Nimbus Infusion Pump Systems (Nimbus Flex, Nimbus PainPro) due to potential battery failure, system errors, drug leakage, flow rate abnormalities, and housing damage. About 52,328 units are affected nationwide.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: FDA Class I classification mandates a minimum severity score of 4 per the rubric. The recalled infusion pumps have multiple potential failure modes that could compromise medication delivery. No deaths or hospitalizations are reported in the source text.

Plain-English summary

InfuTronix LLC is recalling the Nimbus Administration Set, Nimbus Flex, and Nimbus PainPro ambulatory infusion pump systems due to potential failure modes including battery failure, upstream occlusion, system errors, drug product leakage, high or low flow rate, and damaged pump housing.

The recall affects approximately 52,328 units that have been distributed nationwide in the United States. The FDA has classified this as a Class I recall. InfuTronix is removing the devices from the market and will no longer provide device support or availability after June 20, 2024.

The recalled product

Product
Nimbus Administration Set; Nimbus Flex; Nimbus PainPro (a.k.a. Halo Ambulatory Infusion System); Catalog Number IT1025. Ambulatory Infusion Pump and components
Manufacturer
InfuTronix LLC
Hazard
  • battery-failure
  • upstream-occlusion
  • system-error
  • drug-leakage
  • flow-rate-error
  • housing-damage

Distribution

Distributed nationwide across the United States.